Comparative Evaluation of Mucosal Adjuvants for Intranasal Immunization with a Recombinant RSV Prefusion F Protein.

Vaccines (Basel) · 2026 · PMC12945138 · PMID 41746106

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Challenge assessments indicated that on days 2–3 after challenge, mice in the 10 μg and 50 μg PEI groups showed a faster body weight recovery rate than those in the 2.5 μg PEI group, although the differences did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.